Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights

Go back to Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights

Voyager Therapeutics (VYGR) Misses Q4 EPS by 11c

March 15, 2017 7:09 AM EDT

Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $4.01 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

... More